News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Chelsea Therapeutics, Inc. 2Q Loss Narrows on Gain
August 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- Chelsea Therapeutics International Ltd., which is developing a drug candidate to treat low blood pressure, said Wednesday its loss narrowed on a gain from prior impairments on auction-rate securities.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Venture capitalists
Bausch Health Tussles With Activist Investor Carl Icahn After Popping Poison Pill
April 23, 2025
·
1 min read
·
Tristan Manalac
Podcast
Makary’s First Interview, US Manufacturing Push and Lilly vs. Novo in Obesity Pill Race
April 23, 2025
·
1 min read
·
Heather McKenzie
C-suite
Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech
April 22, 2025
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Tempest Axes 80% of Workforce
April 22, 2025
·
180 min read
·
BioSpace Editorial Staff